Literature DB >> 26072169

Wnt/β-catenin pathway involvement in ionizing radiation-induced invasion of U87 glioblastoma cells.

Zhen Dong1, Lin Zhou, Na Han, Mengxian Zhang, Xiaojuan Lyu.   

Abstract

BACKGROUND: Radiotherapy has been reported to promote the invasion of glioblastoma cells; however, the underlying mechanisms remain unclear. Here, we investigated the role of the Wnt/β-catenin pathway in radiation-induced invasion of glioblastoma cells.
METHODS: U87 cells were irradiated with 3 Gy or sham irradiated in the presence or absence of the Wnt/β-catenin pathway inhibitor XAV 939. Cell invasion was determined by an xCELLigence real-time cell analyser and matrigel invasion assays. The intracellular distribution of β-catenin in U87 cells with or without irradiation was examined by immunofluorescence and Western blotting of nuclear fractions. We next investigated the effect of irradiation on Wnt/β-catenin pathway activity using TOP/FOP flash luciferase assays and quantitative polymerase chain reaction analysis of β-catenin target genes. The expression levels and activities of two target genes, matrix metalloproteinase (MMP)-2 and MMP-9, were examined further by Western blotting and zymography.
RESULTS: U87 cell invasiveness was increased significantly by ionizing radiation. Interestingly, ionizing radiation induced nuclear translocation and accumulation of β-catenin. Moreover, we found increased β-catenin/TCF transcriptional activities, followed by up-regulation of downstream genes in the Wnt/β-catenin pathway in irradiated U87 cells. Importantly, inhibition of the Wnt/β-catenin pathway by XAV 939, which promotes degradation of β-catenin, significantly abrogated the pro-invasion effects of irradiation. Mechanistically, XAV 939 suppressed ionizing radiation-triggered up-regulation of MMP-2 and MMP-9, and inhibited the activities of these gelatinases.
CONCLUSION: Our data demonstrate a pivotal role of the Wnt/β-catenin pathway in ionizing radiation-induced invasion of glioblastoma cells, and suggest that targeting β-catenin is a promising therapeutic approach to overcoming glioma radioresistance.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26072169     DOI: 10.1007/s00066-015-0858-7

Source DB:  PubMed          Journal:  Strahlenther Onkol        ISSN: 0179-7158            Impact factor:   3.621


  36 in total

1.  Frizzled 4 regulates stemness and invasiveness of migrating glioma cells established by serial intracranial transplantation.

Authors:  Xun Jin; Hee-Young Jeon; Kyeung Min Joo; Jun-Kyum Kim; Juyoun Jin; Sung Hak Kim; Bong Gu Kang; Samuel Beck; Se Jeong Lee; Joong Kyu Kim; Ae-Kyung Park; Woong-Yang Park; Yun-Jaie Choi; Do-Hyun Nam; Hyunggee Kim
Journal:  Cancer Res       Date:  2011-03-01       Impact factor: 12.701

2.  Postoperative radiotherapy and concomitant temozolomide for elderly patients with glioblastoma.

Authors:  Johanna Gerstein; Kea Franz; Joachim P Steinbach; Valker Seifert; Inge Fraunholz; Christian Weiss; Claus Rödel
Journal:  Radiother Oncol       Date:  2010-09-17       Impact factor: 6.280

3.  Induction of MET by ionizing radiation and its role in radioresistance and invasive growth of cancer.

Authors:  Francesca De Bacco; Paolo Luraghi; Enzo Medico; Gigliola Reato; Flavia Girolami; Timothy Perera; Pietro Gabriele; Paolo M Comoglio; Carla Boccaccio
Journal:  J Natl Cancer Inst       Date:  2011-04-04       Impact factor: 13.506

Review 4.  The Wnt/β-catenin signaling pathway: a potential therapeutic target in the treatment of triple negative breast cancer.

Authors:  Taj D King; Mark J Suto; Yonghe Li
Journal:  J Cell Biochem       Date:  2012-01       Impact factor: 4.429

Review 5.  Wnt/beta-catenin signaling pathway as a novel cancer drug target.

Authors:  Hue H Luu; Ruiwen Zhang; Rex C Haydon; Elizabeth Rayburn; Quan Kang; Weike Si; Jong Kyung Park; Hui Wang; Ying Peng; Wei Jiang; Tong-Chuan He
Journal:  Curr Cancer Drug Targets       Date:  2004-12       Impact factor: 3.428

6.  Proliferation, migration, and invasion of human glioma cells exposed to fractionated radiotherapy in vitro.

Authors:  Jan Gliemroth; Thomas Feyerabend; Christiane Gerlach; Hans Arnold; A Jorge A Terzis
Journal:  Neurosurg Rev       Date:  2003-02-12       Impact factor: 3.042

7.  Dual regulation of Snail by GSK-3beta-mediated phosphorylation in control of epithelial-mesenchymal transition.

Authors:  Binhua P Zhou; Jiong Deng; Weiya Xia; Jihong Xu; Yan M Li; Mehmet Gunduz; Mien-Chie Hung
Journal:  Nat Cell Biol       Date:  2004-09-26       Impact factor: 28.824

8.  Post-radiation increase in VEGF enhances glioma cell motility in vitro.

Authors:  Whoon Jong Kil; Philip J Tofilon; Kevin Camphausen
Journal:  Radiat Oncol       Date:  2012-02-22       Impact factor: 3.481

9.  Epidermal to Mesenchymal Transition and Failure of EGFR-Targeted Therapy in Glioblastoma.

Authors:  Andrej Pala; Georg Karpel-Massler; Richard Eric Kast; Christian Rainer Wirtz; Marc-Eric Halatsch
Journal:  Cancers (Basel)       Date:  2012-05-08       Impact factor: 6.639

10.  Modelling of a targeted nanotherapeutic 'stroma' to deliver the cytokine LIF, or XAV939, a potent inhibitor of Wnt-β-catenin signalling, for use in human fetal dopaminergic grafts in Parkinson's disease.

Authors:  Jing-Wei Zhao; Sean C Dyson; Christina Kriegel; Pam Tyers; Xiaoling He; Tarek M Fahmy; Su M Metcalfe; Roger A Barker
Journal:  Dis Model Mech       Date:  2014-08-01       Impact factor: 5.758

View more
  23 in total

1.  Chemoradiotherapy Resistance in Colorectal Cancer Cells is Mediated by Wnt/β-catenin Signaling.

Authors:  Georg Emons; Melanie Spitzner; Sebastian Reineke; Janneke Möller; Noam Auslander; Frank Kramer; Yue Hu; Tim Beissbarth; Hendrik A Wolff; Margret Rave-Fränk; Elisabeth Heßmann; Jochen Gaedcke; B Michael Ghadimi; Steven A Johnsen; Thomas Ried; Marian Grade
Journal:  Mol Cancer Res       Date:  2017-08-15       Impact factor: 5.852

2.  MiRNA-21 functions in ionizing radiation-induced epithelium-to-mesenchymal transition (EMT) by downregulating PTEN.

Authors:  Zheng Liu; Xin Liang; Xueping Li; Xiaodan Liu; Maoxiang Zhu; Yongqing Gu; Pingkun Zhou
Journal:  Toxicol Res (Camb)       Date:  2019-02-28       Impact factor: 3.524

3.  Distinct response to GDF15 knockdown in pediatric and adult glioblastoma cell lines.

Authors:  Mirella Baroni; Suely Kazue Nagahashi Marie; Paola Fernanda Fedatto; Augusto Faria Andrade; Veridiana Kill Suazo; Gustavo Alencastro Veiga Cruzeiro; Rosane de Paula Queiroz; Luiz Gonzaga Tone; Carlos Alberto Scrideli
Journal:  J Neurooncol       Date:  2018-04-18       Impact factor: 4.130

Review 4.  Emerging role of tumor cell plasticity in modifying therapeutic response.

Authors:  Siyuan Qin; Jingwen Jiang; Yi Lu; Edouard C Nice; Canhua Huang; Jian Zhang; Weifeng He
Journal:  Signal Transduct Target Ther       Date:  2020-10-07

Review 5.  Phenotypic Transition as a Survival Strategy of Glioma.

Authors:  Tomotsugu Ichikawa; Yoshihiro Otani; Kazuhiko Kurozumi; Isao Date
Journal:  Neurol Med Chir (Tokyo)       Date:  2016-05-11       Impact factor: 1.742

Review 6.  Induction of metastasis, cancer stem cell phenotype, and oncogenic metabolism in cancer cells by ionizing radiation.

Authors:  Su Yeon Lee; Eui Kyong Jeong; Min Kyung Ju; Hyun Min Jeon; Min Young Kim; Cho Hee Kim; Hye Gyeong Park; Song Iy Han; Ho Sung Kang
Journal:  Mol Cancer       Date:  2017-01-30       Impact factor: 27.401

7.  Daam1 activates RhoA to regulate Wnt5a‑induced glioblastoma cell invasion.

Authors:  Guiyang Liu; Ting Yan; Xiaorong Li; Jianhui Sun; Bo Zhang; Hongjie Wang; Yichao Zhu
Journal:  Oncol Rep       Date:  2017-12-01       Impact factor: 3.906

Review 8.  A molecular view of the radioresistance of gliomas.

Authors:  Xuetao Han; Xiaoying Xue; Huandi Zhou; Ge Zhang
Journal:  Oncotarget       Date:  2017-10-11

9.  Combination of AQP1 and β-catenin expression is an independent prognosis factor in astrocytoma patients.

Authors:  Huikun Zhang; Fengxia Qin; Limin Yang; Jia He; Xiaoli Liu; Ying Shao; Zhifang Guo; Ming Zhang; Wenliang Li; Li Fu; Feng Gu; Yongjie Ma
Journal:  Oncotarget       Date:  2017-07-26

10.  Blocking epithelial-to-mesenchymal transition in glioblastoma with a sextet of repurposed drugs: the EIS regimen.

Authors:  Richard E Kast; Nicolas Skuli; Georg Karpel-Massler; Guido Frosina; Timothy Ryken; Marc-Eric Halatsch
Journal:  Oncotarget       Date:  2017-06-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.